Valuation : CVRx, Inc.

Market Cap 80.99M 69.86M 65.72M 59.87M 113M 7.69B 113M 777M 302M 3.91B 304M 297M 12.96B P/E 2026 *
-1.51x
P/E 2027 * -1.59x
Enterprise Value 91.49M 78.92M 74.24M 67.63M 127M 8.68B 128M 878M 342M 4.42B 344M 336M 14.65B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.87x
Free-Float
80.18%
Yield 2026 *
-
Yield 2027 * -
1 day+1.48%
1 week-5.81%
Current month+4.05%
1 month-44.00%
3 months-43.28%
6 months-62.53%
Current year-56.62%
1 week 2.81
Extreme 2.81
3.29
1 month 2.2
Extreme 2.2
6
Current year 2.2
Extreme 2.2
9.84
1 year 2.2
Extreme 2.2
11.3
3 years 2.2
Extreme 2.2
33.14
5 years 2.2
Extreme 2.2
33.14
10 years 2.2
Extreme 2.2
33.14
Manager TitleAgeSince
Chief Executive Officer 60 2024-02-11
Chief Operating Officer 57 2025-08-10
Chief Tech/Sci/R&D Officer 66 2024-05-22
Director TitleAgeSince
Director/Board Member 61 2008-09-30
Director/Board Member 57 2020-06-30
Director/Board Member 52 2020-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26 Buy

Chief Operating Officer

26,223 0.0988%
8/12/26 Sell

Chief Operating Officer

-1,309 0.0049%
6/1/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+2.14%-5.81%-60.16%-82.10% 80.99M
+0.52%+0.42%+20.38%+23.78% 12.71B
+0.74%0.00%+19.86%+27.60% 6.91B
+5.15%+21.75% - - 6.3B
-5.16%-10.51%+37.73%+23.26% 6.29B
-1.80%-3.28%-19.74%+45.46% 5.17B
-0.73%-1.78%-31.61%-22.51% 3.88B
+2.13%-0.87%+45.49%-17.20% 2.02B
-2.31%-5.57%-1.17%+134.39% 1.79B
-2.82%-3.28%+48.97%-14.84% 1.63B
Average -0.31%+0.16%+6.64%+13.09% 4.68B
Weighted average by Cap. -0.15%+1.30%+14.18%+23.77%

Financials

2026 *2027 *
Net sales 58.85M 50.77M 47.75M 43.5M 81.81M 5.59B 82.25M 565M 220M 2.84B 221M 216M 9.42B 66.18M 57.09M 53.7M 48.92M 92M 6.28B 92.49M 635M 247M 3.19B 248M 243M 10.59B
Net income -53.45M -46.11M -43.37M -39.51M -74.3M -5.07B -74.7M -513M -200M -2.58B -201M -196M -8.56B -52.14M -44.97M -42.3M -38.54M -72.47M -4.95B -72.86M -500M -195M -2.52B -196M -191M -8.35B
Net Debt 10.5M 9.06M 8.52M 7.76M 14.6M 997M 14.68M 101M 39.21M 507M 39.43M 38.58M 1.68B 42.94M 37.04M 34.84M 31.74M 59.69M 4.08B 60.01M 412M 160M 2.07B 161M 158M 6.87B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
26-09-02 US$3.085 +1.48% 154,752
26-09-01 US$3.040 +2.70% 780,721
26-08-31 US$2.960 +0.34% 737,784
26-08-28 US$2.950 -2.96% 497,116
26-08-27 US$3.040 -7.03% 449,034
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
3.040USD
Average target price
4.583USD
Spread / Average Target
+50.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock